CYP24, the enzyme that catabolizes the antiproliferative agent vitamin D, is increased in lung cancer

被引:81
|
作者
Parise, Robert A.
Egorin, Merrill J.
Kanterewicz, Beatriz
Taimi, Mohammed
Petkovich, Martin
Lew, April M.
Chuang, Samuel S.
Nichols, Mark
El-Hefnawy, Talal
Hershberger, Pamela A.
机构
[1] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA
[2] Univ Pittsburgh, Sch Med, Dept Pharmacol, Pittsburgh, PA USA
[3] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA USA
[4] Cytochroma Inc, Markham, ON, Canada
关键词
1; alpha-; 25-dihydroxyvitamin D-3; 25-hydroxyvitamin D-3-24 hydroxylase; CYP24; nonsmall cell lung cancer;
D O I
10.1002/ijc.22058
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1 alpha,25-Dihydroxyvitamin D-3 (1,25D(3)) displays potent antiproliferative activity in a variety of tumor model systems and is currently under investigation in clinical trials in cancer. Studies were initiated to explore its potential in nonsmall cell lung cancer (NSCLC), as effective approaches to the treatment of that disease are needed. In evaluating factors that may affect activity in NSCLC, the authors found that CYP24 (25-hydroxyvitamin D3-24-hydroxylase), the enzyme that catabolizes 1,25D3, is frequently expressed in NSCLC cell lines but not in the nontumorigenic bronchial epithelial cell line, Beas2B. CYP24 expression by RT-PCR was also detected in 10/18 primary lung tumors but in only 1/11 normal lung tissue specimens. Tumor-specific CYP24 upregulation was confirmed at the protein level via immunoblot analysis of patient-matched normal lung tissue and lung tumor extracts. Enzymatically active CYP24 is expected to desensitize NSCLC cells to 1,25D3. The authors therefore implemented a high performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) assay for 1,25D(3) and its CYP24-generated metabolites to determine whether NSCLC cells express active enzyme. Analysis of NSCLC cell cultures revealed time-dependent loss of 1,25D3 coincident with the appearance of CYP24-generated metabolites. MK-24(S)-S(O)(NH)-Ph-1, a specific inhibitor of CYP24, slowed the loss of 1,25D3 and increased 1,25D3 half-life. Furthermore, combination of 1,25D3 with MK-24(S)-S(O)(NH)-Pb-1 resulted in a significant decrease in the concentration of 1,25D3 required to achieve maximum growth inhibition in NSCLC cells. These data suggest that increased CYP24 expression in lung tumors restricts 1,25D3 activity and support the preclinical evaluation of CYP24 inhibitors for lung cancer treatment. (c) 2006 Wiley-Liss, Inc.
引用
收藏
页码:1819 / 1828
页数:10
相关论文
共 50 条
  • [31] 1,25(OH)2D, the preferred substrate for CYP24
    Jones, G
    Tenenhouse, HS
    JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 (01) : 179 - 180
  • [32] Valproic acid potentiates vitamin D receptor-mediated induction of CYP24 gene - A consequence for drug-induced osteomalacia
    Vrzal, R.
    Novotna, A.
    Doricakova, A.
    Bitmann, M.
    Pavek, P.
    Dvorak, Z.
    FEBS JOURNAL, 2010, 277 : 153 - 153
  • [33] Oestradiol protects 1.25 dihydroxyvitamin D from catabolism by CYP24 in intestinal cells
    O'Loughlin, P. D.
    Tyson, J.
    Anderson, P. H.
    Morris, H. A.
    BONE, 2009, 44 : S62 - S62
  • [34] Valproic acid augments vitamin D receptor-mediated induction of CYP24 by vitamin D3: A possible cause of valproic acid-induced osteomalacia?
    Vrzal, Radim
    Doricakova, Aneta
    Novotna, Aneta
    Bachleda, Petr
    Bitman, Michal
    Pavek, Petr
    Dvorak, Zdenek
    TOXICOLOGY LETTERS, 2011, 200 (03) : 146 - 153
  • [35] Regulation of CYP24 splicing by 1,25-dihydroxyvitamin D3 in human colon cancer cells
    Peng, Xinjian
    Tiwari, Nishant
    Roy, Sarbani
    Yuan, Liang
    Murillo, Genoveva
    Mehta, Rajeshwari R.
    Benya, Richard V.
    Mehta, Rajendra G.
    JOURNAL OF ENDOCRINOLOGY, 2012, 212 (02) : 207 - 215
  • [36] Overexpression of the vitamin D degrading enzyme CYP24A1 in highly proliferative tumors
    Hoebaus, J.
    Fetahu, I. Sh.
    Aggarwal, A.
    Hummel, D. M.
    Mesteri, I.
    Kallay, E.
    BONE, 2012, 51 (06) : S5 - S5
  • [37] ANDROGEN-SPECIFIC REGULATION OF CYP24 IN HUMAN PROSTATE CANCER CELL LINES
    Mukherjee, Sarmistha
    Sahin, Aysegul
    Addai, Josephine
    Stewart, Julie N.
    Lamb, Dolores J.
    JOURNAL OF ANDROLOGY, 2010, : 44 - 44
  • [38] Induction of the vitamin D 24-hydroxylase (CYP24) by 1,25-dihydroxyvitamin D3 is regulated by parathyroid hormone in UMR106 osteoblastic cells
    Armbrecht, HJ
    Hodam, TL
    Boltz, MA
    Partridge, NC
    Brown, AJ
    Kumar, VB
    ENDOCRINOLOGY, 1998, 139 (08) : 3375 - 3381
  • [39] Quantification of mRNA for the vitamin D metabolizing enzymes CYP27B1 and CYP24 and vitamin D receptor in kidney using real-time reverse transcriptase-polymerase chain reaction
    Anderson, PH
    O'Loughlin, PD
    May, BK
    Morris, HA
    JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2003, 31 (01) : 123 - 132
  • [40] CYP24A1 and the Metabolism of Vitamin D
    Bushong, Wednesday
    Hollman, Cassie
    Lee, Sarah
    Akers, Karlene
    Akers, Landon
    Bitterman, Jamie
    Stout, C. David
    FASEB JOURNAL, 2010, 24